Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma.

Soliman HH, Nagy H, Kotb N, Alm El-Din MA.

Int J Biol Markers. 2012 Jul 19;27(2):e125-31. doi: 10.5301/JBM.2012.9097.

PMID:
22388957
3.

Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.

Mukozu T, Nagai H, Matsui D, Kanekawa T, Sumino Y.

Anticancer Res. 2013 Mar;33(3):1013-21.

PMID:
23482775
4.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.

PMID:
18422961
5.

Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.

Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.

Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1417-24.

PMID:
19950803
6.

Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.

Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R.

Am J Gastroenterol. 2000 Apr;95(4):1036-40.

PMID:
10763956
7.

Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.

Paul SB, Gulati MS, Sreenivas V, Madan K, Gupta AK, Mukhopadhyay S, Acharya SK.

Oncology. 2007;72 Suppl 1:117-23. Epub 2007 Dec 13.

PMID:
18087192
8.

Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.

Hsieh MY, Lin ZY, Chuang WL.

Kaohsiung J Med Sci. 2011 Aug;27(8):314-22. doi: 10.1016/j.kjms.2011.03.008. Epub 2011 May 8.

9.

Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.

Tangkijvanich P, Tosukhowong P, Bunyongyod P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P, Poovorawan Y.

Southeast Asian J Trop Med Public Health. 1999 Mar;30(1):110-4.

PMID:
10695798
10.

Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.

Cui R, Wang B, Ding H, Shen H, Li Y, Chen X.

Chin Med J (Engl). 2002 Jan;115(1):42-5.

PMID:
11930656
11.

The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.

Huo TI, Hsia CY, Chu CJ, Huang YH, Lui WY, Wu JC, Lee PC, Chi CW, Lee SD.

J Surg Oncol. 2007 Jun 15;95(8):645-51.

PMID:
17530668
12.

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.

Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, Wang N, Niu Y, Wu Z, Zhou J, Qiu SJ, Shi YH, Yu B, Tang N, Chu W, Wang M, Wu J, Zhang Z, Yang S, Gu J, Wang H, Qin W.

Lancet Oncol. 2012 Aug;13(8):817-26. doi: 10.1016/S1470-2045(12)70233-4. Epub 2012 Jun 26. Erratum in: Lancet Oncol. 2015 Jan;16(1):e6.

PMID:
22738799
13.

Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.

Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, Satomura S, Schwartz ME.

Am J Gastroenterol. 2007 Oct;102(10):2196-205. Epub 2007 Jul 7.

PMID:
17617202
14.

Activity of serum angiotensin-converting enzyme as a tumour marker of hepatocellular carcinoma.

Kardum D, Huskic J, Fabijanic D, Banic M, Buljevac M, Kujundzic M, Loncar B.

Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1209-13.

PMID:
10563528
15.

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.

Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS.

Hepatology. 2003 May;37(5):1114-21.

PMID:
12717392
16.

Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma.

Yagmur E, Rizk M, Stanzel S, Hellerbrand C, Lammert F, Trautwein C, Wasmuth HE, Gressner AM.

Eur J Gastroenterol Hepatol. 2007 Sep;19(9):755-61.

PMID:
17700260
17.

Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.

Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G.

Anticancer Res. 2003 Mar-Apr;23(2C):1747-53.

PMID:
12820452
18.

Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.

Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P.

J Gastroenterol Hepatol. 2010 Jan;25(1):129-37. doi: 10.1111/j.1440-1746.2009.05988.x. Epub 2009 Sep 27.

PMID:
19793164
20.

Evaluation of transforming growth factor alpha and vascular endothelial growth factor in diagnosis of hepatocellular carcinoma.

El-Sherif WT, Makhlouf NA, El-Gendi SS, Hassan HI, Herdan OM.

Egypt J Immunol. 2012;19(2):53-65.

PMID:
23885407
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk